Synthesis, Spectral Characterization, and In Vitro Cellular Activities of Metapristone, a Potential Cancer Metastatic Chemopreventive Agent Derived from Mifepristone (RU486)
Open Access
- 18 January 2014
- journal article
- Published by Springer Nature in The AAPS Journal
- Vol. 16 (2) , 289-298
Abstract
Mifepristone (RU486) is marketed and used widely by women as an abortifacient, and experimentally for psychotic depression and anticancer treatments. After administration, metapristone is found to be...Keywords
This publication has 37 references indexed in Scilit:
- Synergistic Lethality of Mifepristone and LY294002 in Ovarian Cancer CellsCancer Growth and Metastasis, 2013
- Distinguishing features of endometrial pathology after exposure to the progesterone receptor modulator mifepristoneHuman Pathology, 2011
- HexServer: an FFT-based protein docking server powered by graphics processorsNucleic Acids Research, 2010
- Molecular Switch in the Glucocorticoid Receptor: Active and Passive Antagonist ConformationsJournal of Molecular Biology, 2010
- Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblastsHuman Reproduction Update, 2006
- Cancer Interaction with the Bone MicroenvironmentThe American Journal of Pathology, 2006
- Liver-Selective Glucocorticoid Antagonists: A Novel Treatment for Type 2 DiabetesJournal of Medicinal Chemistry, 2004
- Effect of Hypoxia on Cellular Adhesion to Vitronectin and FibronectinBiochemical and Biophysical Research Communications, 2001
- Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant womenContraception, 1993
- Plasma concentrations and receptor binding of RU 486 and its metabolites in humansThe Journal of Steroid Biochemistry and Molecular Biology, 1987